PE33896A1 - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRIC DISCOMFORT - Google Patents

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRIC DISCOMFORT

Info

Publication number
PE33896A1
PE33896A1 PE27413595A PE27413595A PE33896A1 PE 33896 A1 PE33896 A1 PE 33896A1 PE 27413595 A PE27413595 A PE 27413595A PE 27413595 A PE27413595 A PE 27413595A PE 33896 A1 PE33896 A1 PE 33896A1
Authority
PE
Peru
Prior art keywords
treatment
pharmaceutical composition
nizatidine
gastric discomfort
tablet
Prior art date
Application number
PE27413595A
Other languages
Spanish (es)
Inventor
Dolores Dimaria
Michael Alan Brandley
Jeanette Louise Brandley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of PE33896A1 publication Critical patent/PE33896A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA ESTABLE QUE ES USADA EN EL TRATAMIENTO DE MALESTARES GASTROINTESTINALES ASOCIADAS CON HIPERACIDEZ, LA CUAL COMPRENDE: a) NIZATIDINA; b) UN ANTIACIDO SELECCIONADO DEL GRUPO CONSISTENTE DE CARBONATO O MAGALDRATO. LAS FORMAS DE PRESENTACION SON LIQUIDAS O SOLIDAS, PUDIENDO SER CAPSULAS O TABLETAS, EN EL CASO DE SER TABLETA PUEDE SER DE UNA O DOS CAPAS; SI LA TABLETA ES DE UNA CAPA LA CANTIDAD EFECTIVA DE NIZATIDINA PUEDE SER DE 625 mg, 225mg, 75mg O 25mg; SI ES DE DOBLE CAPA, LA NIZATIDINA PUEDE PRESENTAR CANTIDADES EFECTIVAS DE 625 mg, 225 mg, 75 mg o 25 mgIT REFERS TO A STABLE PHARMACEUTICAL COMPOSITION THAT IS USED IN THE TREATMENT OF GASTROINTESTINAL DISCOMFORTS ASSOCIATED WITH HYPERACITY, WHICH INCLUDES: a) NIZATIDINE; b) AN ANTICIDE SELECTED FROM THE CONSISTENT GROUP OF CARBONATE OR MAGALDRATE. THE FORMS OF PRESENTATION ARE LIQUID OR SOLID, MAY BE CAPSULES OR TABLETS, IN THE CASE OF BEING A TABLET, IT MAY BE OF ONE OR TWO LAYERS; IF THE TABLET IS OF A LAYER, THE EFFECTIVE AMOUNT OF NIZATIDINE MAY BE 625 mg, 225mg, 75mg OR 25mg; IF DOUBLE LAYER, NIZATIDINE MAY HAVE EFFECTIVE AMOUNTS OF 625 mg, 225 mg, 75 mg or 25 mg

PE27413595A 1994-07-20 1995-07-18 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRIC DISCOMFORT PE33896A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27763294A 1994-07-20 1994-07-20

Publications (1)

Publication Number Publication Date
PE33896A1 true PE33896A1 (en) 1996-09-02

Family

ID=23061722

Family Applications (1)

Application Number Title Priority Date Filing Date
PE27413595A PE33896A1 (en) 1994-07-20 1995-07-18 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTRIC DISCOMFORT

Country Status (4)

Country Link
AU (1) AU3132495A (en)
CO (1) CO4410201A1 (en)
PE (1) PE33896A1 (en)
WO (1) WO1996002262A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019259791B2 (en) 2018-04-27 2024-03-28 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
AU665944B2 (en) * 1991-04-04 1996-01-25 Procter & Gamble Company, The Chewable antacid compositions
HU213203B (en) * 1991-04-04 1997-03-28 Procter & Gamble Process for producing of ingestible pharmaceutical compositions comprising 3-(i-menthoxy)-propane-1,2-diol for treating upper gastrointestinal tract symptoms
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
CO4410201A1 (en) 1997-01-09
AU3132495A (en) 1996-02-16
WO1996002262A3 (en) 1997-02-13
WO1996002262A2 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
ES2195308T3 (en) PHARMACEUTICAL PHENOFIBRATE COMPOSITION THAT PRESENTS A HIGH BIODISPONIBILITY, AND METHOD FOR PREPARATION.
UY27296A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN
PE20000954A1 (en) PHARMACEUTICAL COMPOSITIONS
DK0632720T3 (en) Hydroxyethyl cellulose based depot dosage forms
ES2191973T3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF MOLECULAR IODINE.
ES2060825T3 (en) A THERAPEUTIC SYSTEM FOR DELAYED AND CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES BY VIA PERCUTANEA OR THROUGH THE MUCOSA.
UY24875A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TETRAHYDROLYPSTATIN
MX174336B (en) COMPOSITIONS CONTAINING L-CARNITINE L-TARTRATE AND PROCEDURE FOR ITS PREPARATION
TR200001761T2 (en) A pair of capsules for the application of active principles in multiple therapies.
AR042051A1 (en) COMBINED TREATMENT AGAINST CANCER WITH AN ANTI-CANCERIGENE COMPOUND ACTIVATED BY GLUTATIONA S- TRANSFERASA (GST) AND OTHER TREATMENT AGAINST CANCER
ES2097787T3 (en) PHARMACEUTICAL COMPOSITION FOR THE RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES PRESENTED BY A PREVALENTLY TOPICAL MEDICATION ACTION AT THE COLON LEVEL.
BR9506028A (en) Oral dosage form of multiple unit dosage in tablet processes for preparing it for the inhibition of gastric acid secretion in mammals and in man and for the treatment of inflammatory gastrointestinal diseases in mammals and in man and transverse pressure ampoule packaging
CL2008000489A1 (en) METHOD FOR ADJUSTING THE PROFILE OF LEVELS IN BLOOD OR THE PERMEATION OF A PHARMACY FROM A COMPOSITION; AND COMPOSITION FOR TRANSDERMAL ADMINISTRATION THAT INCLUDES SUCH PHARMACO AND A PHARMACEUTICALLY ACCEPTABLE VEHICLE.
CO5611096A2 (en) PHARMACEUTICAL DOSAGE FORM FOR MUCOSAL ADMINISTRATION
ES2117146T3 (en) PHARMACEUTICAL TABLET ABLE TO RELEASE ONE OR MULTIPLE MEDICINAL SUBSTANCES AT DIFFERENT SPEEDS.
ES2166769T3 (en) COMPRESSED PHARMACEUTICAL CONTROLLED LIBERATION PRESENTING LENTICULAR FORM.
KR830005854A (en) Method for preparing alkaline analgesic capsule
PE58998A1 (en) COMBINED THERAPY FOR OSTEOPOROSIS
CY1112738T1 (en) A COMBINED COMPOSITION CONTAINING Ibuprofen And Paracetamol
WO2006021160A8 (en) Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
ATE506284T1 (en) BLISTER CARD FOR PHARMACEUTICAL TREATMENT
BR9807992A (en) Pills to swallow which comprise paracetamol
AR011106A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DIABETES MELLITUS TYPE 2,
CL2004000577A1 (en) BIOADHESIVE TABLET WITH CONCENTRIC DEPRESSIONS, PARALLELS, RECTORS AND / OR CURVES THAT INCLUDES A BIOADHESIVE AUXILIARY SUBSTANCE AND A LUBRICANT AGENT WHERE THE RELATIONSHIP BETWEEN THEM IS FROM 1: 1300 TO 1: 1.
AR036085A1 (en) DOSAGE FORMS AND PROCEDURE FOR MANUFACTURING

Legal Events

Date Code Title Description
FC Refusal